Novogene’s End-to-End Proteomic Platform for Biomarker Discovery
Broad Research Applications of Protein Biomarker Discovery
A biomarker is any measurable biological molecules that can be assessed and measured as a potential index of physiological status or pharmacological responses to treatments. Scientists and researchers screen proteins, particularly low-abundance proteins extracted from tissues, blood, urine and other body fluids, to obtain indicators of biological processes.
Identifying these trace proteins demands comprehensive, unbiased proteomic profiling, for which mass spectrometry acts as a powerful tool for large-scale protein identification and quantification. At Novogene, we deploy state-of-the-art mass spectrometers to generate high-throughput, reproducible and ultra-precise data with unparalleled performance. Coupled with our robust sample pretreatment workflows, our platforms deliver superior detection depth and proteome coverage for all sample types. For biomarker identification, algorithms and AI-driven bioinformatic pipelines enable fast, reliable candidate screening. This fully integrated, end-to-end workflow underpins every stage of your biomarker discovery project.
Broad Research Applications of Protein Biomarker Discovery
Protein biomarker discovery uses a large cohort or small sample set to screen differentially expressed protein candidates across study groups, laying a foundation for disease screening, diagnosis and therapeutic monitoring.
1. Cancer Research
Profile the proteome of the tumor microenvironment and identify predictive biomarkers for cancer prognosis and treatment response
2. Immunology
Uncover protein signatures underlying Immune activities, inflammatory response and immune-related pathological mechanisms.
3. Drug Development
Characterize pharmacodynamic profiles and drug molecular effects to accelerate pre-clinical studies
Why Choose Novogene for Your Biomarker Discovery Projects?
1. Superior Data Quality
We excel at processing challenging sample types, including diverse body fluids and biopsies;
Reliable plasma/serum proteomics for sensitive low-abundance biomarker detection
2. Bespoke Bioinformatics Solutions
We deliver custom bioinformatics pipelines for your biomarker research objectives
3. Customized for Your Success
Our team collaborates with you on study design to guarantee biologically meaningful, interpretable outputs
4. Flexible Strategies
We offer selectable proteomic detection workflows to match your research goals and budget
Figure 1. Measured data from different sample types (LC gradient: 24 min)
End-to-End Workflow at Novogene
Our protein identification workflow integrates three key components – advanced instrumentation, validated procedures, and expert analysis – to deliver reliable results. The standard procedure is outlined below:
1. Sample Preparation
Protein extraction and cleanup from tissues, cells, body fluids, and so on;
Compatible with minimal sample input
2. Protein Digestion
In-solution / on-beads / in-gel trypsin digestion into peptides
3. LC-MSMS detection
Sample QC and protein identification;
Ultra-deep proteome coverage;
Sensitive detection of low-abundance proteins
4. Database Search & Bioinformatics
Covers all application areas & data types
Multi-algorithm integrated feature selection;
Meta-learner driven ensemble learning;
Convenient, user-friendly delivery
Figure 2. AI-powered bioinformatic workflow for biomarker discovery at Novogene